GlassScriptPhysician profile
Deepak Ozhathil
NPI 1366706293
$2,058.84
in general payments reported to CMS, 2019-2025
12 companies · $430 in 2025
The $430 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $100 · 2021: $358 · 2022: $467 · 2023: $526 · 2024: $178 · 2025: $430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,112 · Entertainment: $21.92.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,112.20 |
| Entertainment | $21.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $880.80 | 2021-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Avita Medical Americas, LLC | $312.53 | 2024-2025 | Permeaderm, Cohealyx, Recell |
| Access Pro Medical, LLC | $185.45 | 2023-2025 | Matriderm, Matriderm |
| Molnlycke Health Care US, LLC | $170.56 | 2022 | |
| Medline Industries LP | $164.00 | 2021-2025 | |
| Kerecis Limited | $150.49 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Kci USA, INC. | $100.00 | 2019 | |
| Aroa Biosurgery Incorporated | $25.18 | 2025 | |
| Argentum Medical | $21.92 | 2025 | |
| Smith+Nephew, INC. | $19.10 | 2022 | |
| Vericel Corporation | $15.03 | 2025 | |
| Btg International INC. | $13.78 | 2025 | Aurlumyn |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepak Ozhathil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.